Conversation with The Cancer LetterFree Giusti: The $40 million multiple myeloma dataset will help predict risk and clinical response February 10, 2017Vol.43 No.06By Matthew Bin Han Ong
Steve Hahn takes over day to day operations at MD Anderson February 10, 2017Vol.43 No.06By Paul Goldberg
Free GAO report: FDA underestimated actual cancer risk, clearing 25 versions of morcellators in over 20 years February 10, 2017Vol.43 No.06By Matthew Bin Han Ong
FreeObituary LeMaistre, a pioneer of cancer prevention and former MD Anderson president, dies at 92 February 03, 2017Vol.43 No.05By Otis W. Brawley
Cancer groups: Trump travel ban could “retard scientific progress and adversely affect public health” February 03, 2017Vol.43 No.05By Matthew Bin Han Ong
Soon-Shiong’s journey from “Rocket Ship” to “MoonShot”—with lots of confusion February 03, 2017Vol.43 No.05
Soon-Shiong drops “MoonShot” trademark, but MD Anderson suit remains unresolved February 03, 2017Vol.43 No.05By Paul Goldberg
MD Anderson posts $169 million loss for first four months of fiscal 2017 January 27, 2017Vol.43 No.04By Paul Goldberg
Study Shows Only Nuclear-Localized AR-V7 Predictive of Benefit for Patients with Metastatic Disease January 25, 2017Vol.40 No.01
